Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locusKate Lawrenson, Ji‐Yeob Choi, Siddhartha Kar et al.|Nature Communications|2016Cited by 99
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian CancersHuong Meeks, Pascal Guénel, Daniel Barrowdale et al.|JNCI Journal of the National Cancer Institute|2015Cited by 92
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancerAntoinette Hollestelle, Saundra S. Buys, Frederieke H. van der Baan et al.|Gynecologic Oncology|2015Cited by 20